🔗 Visit the ClinicalTrials.gov page for NCT01791686
Rank | Title | Journal | Year | PubWeight™‹?› |
---|---|---|---|---|
1 | Biologics for the treatment of autoimmune renal diseases. | Nat Rev Nephrol | 2016 | 0.97 |
2 | Update on C3 glomerulopathy. | Nephrol Dial Transplant | 2014 | 0.94 |
3 | Therapeutic control of complement activation at the level of the central component C3. | Immunobiology | 2015 | 0.94 |
4 | Applying complement therapeutics to rare diseases. | Clin Immunol | 2015 | 0.87 |
5 | Complement involvement in kidney diseases: From physiopathology to therapeutical targeting. | World J Nephrol | 2015 | 0.80 |
6 | Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN. | World J Nephrol | 2016 | 0.76 |